586 related articles for article (PubMed ID: 33407563)
1. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis.
Zhou L; Li J; Tang Y; Yang M
J Transl Med; 2021 Jan; 19(1):8. PubMed ID: 33407563
[TBL] [Abstract][Full Text] [Related]
2. Loss of exosomal miR-200b-3p from hypoxia cancer-associated fibroblasts promotes tumorigenesis and reduces sensitivity to 5-Flourouracil in colorectal cancer via upregulation of ZEB1 and E2F3.
Gong W; Guo Y; Yuan H; Chai R; Wan Z; Zheng B; Hu X; Chen B; Gao S; Dai Q; Yu P; Tu S
Cancer Gene Ther; 2023 Jun; 30(6):905-916. PubMed ID: 36890211
[TBL] [Abstract][Full Text] [Related]
3. Exosomal-miR-522-3p derived from cancer-associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancer.
Zhang J; Pan Y; Jin L; Yang H; Cao P
J Gastroenterol Hepatol; 2024 Jan; 39(1):107-120. PubMed ID: 37984826
[TBL] [Abstract][Full Text] [Related]
4. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts-derived exosome-mediated transfer of miR-345-5p promotes the progression of colorectal cancer by targeting CDKN1A.
Shi W; Liu Y; Qiu X; Yang L; Lin G
Carcinogenesis; 2023 Jun; 44(4):317-327. PubMed ID: 37052230
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis.
Hu JH; Tang HN; Wang YH
Cancer Gene Ther; 2024 Feb; 31(2):259-272. PubMed ID: 38052858
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
8. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-625-3p secreted by cancer-associated fibroblasts in colorectal cancer promotes EMT and chemotherapeutic resistance by blocking the CELF2/WWOX pathway.
Zhang Y; Yin C; Wei C; Xia S; Qiao Z; Zhang XW; Yu B; Zhou J; Wang R
Pharmacol Res; 2022 Dec; 186():106534. PubMed ID: 36336217
[TBL] [Abstract][Full Text] [Related]
10. Exosomal circ_0084043 derived from colorectal cancer-associated fibroblasts promotes
Payervand N; Pakravan K; Razmara E; Vinu KK; Ghodsi S; Heshmati M; Babashah S
Heliyon; 2024 Jun; 10(11):e31584. PubMed ID: 38828320
[TBL] [Abstract][Full Text] [Related]
11. Loss of exosomal micro-RNA-200b-3p from hypoxia cancer-associated fibroblasts reduces sensitivity to 5-flourouracil in colorectal cancer through targeting high-mobility group box 3.
Yuan H; Chen B; Chai R; Gong W; Wan Z; Zheng B; Hu X; Guo Y; Gao S; Dai Q; Yu P; Tu S
Front Oncol; 2022; 12():920131. PubMed ID: 36276139
[TBL] [Abstract][Full Text] [Related]
12. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
Jiang Y; Wang K; Lu X; Wang Y; Chen J
Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-93-5p from cancer-associated fibroblasts confers malignant phenotypes on bladder cancer cells by targeting PAFAH1B1.
Lu X; Wang J; Dong B; Wang L; Liu Y
Anticancer Drugs; 2023 Mar; 34(3):439-450. PubMed ID: 36441004
[TBL] [Abstract][Full Text] [Related]
15. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis.
Li BL; Lu W; Qu JJ; Ye L; Du GQ; Wan XP
J Cell Physiol; 2019 Mar; 234(3):2943-2953. PubMed ID: 30146796
[TBL] [Abstract][Full Text] [Related]
16. MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway.
Yang F; Yan Y; Yang Y; Hong X; Wang M; Yang Z; Liu B; Ye L
Cell Signal; 2020 Sep; 73():109675. PubMed ID: 32446904
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
19. CAFs-derived small extracellular vesicles circN4BP2L2 promotes proliferation and metastasis of colorectal cancer via miR-664b-3p/HMGB3 pathway.
Yang K; Zhang F; Luo B; Qu Z
Cancer Biol Ther; 2022 Dec; 23(1):404-416. PubMed ID: 35722996
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblast-derived exosome miR-181b-3p promotes the occurrence and development of colorectal cancer by regulating SNX2 expression.
Jiang Y; Qiu Q; Jing X; Song Z; Zhang Y; Wang C; Liu K; Ye F; Ji X; Luo F; Zhao R
Biochem Biophys Res Commun; 2023 Jan; 641():177-185. PubMed ID: 36535076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]